Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Knoll

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Social Science & Medicine (1982)|November 5, 2025
Adults with sickle-cells in a migration-driven rare disease setting: Therapeutic remoteness and graphic medicine in AustriaEva-Maria Knoll
Social Science & Medicine (1982)|February 13, 2026
Rare diseases, global health, and local contextsMałgorzata Rajtar, Eva-Maria Knoll
Gates Open Research|August 11, 2023
Worldwide Index of Serotype-Specific Pneumococcal Antibody Responses (WISSPAR): A curated database of clinical trial dataStephanie Perniciaro, Dominic Cooper-Wooton, Maria Knoll, et al.
Health Affairs (Project Hope)|October 14, 2016
Modeling The Economic Burden Of Adult Vaccine-Preventable Diseases In The United StatesSachiko Ozawa, Allison Portnoy, Hiwote Getaneh, et al.
Lancet (London, England)|June 13, 2006
Pneumococcal vaccination in developing countriesOrin S Levine, Katherine L O'Brien, Maria Knoll, et al.
The Lancet. Infectious Diseases|February 22, 2016
Effect of the introduction of pneumococcal conjugate vaccination on invasive pneumococcal disease in The Gambia: a population-based surveillance studyGrant A Mackenzie, Philip C Hill, David J Jeffries, et al.
The Lancet. Infectious Diseases|July 19, 2021
Impact of the introduction of pneumococcal conjugate vaccination on invasive pneumococcal disease and pneumonia in The Gambia: 10 years of population-based surveillance, Grant A Mackenzie, Philip C Hill, et al.
The Lancet. Infectious Diseases|June 12, 2017
Impact of the introduction of pneumococcal conjugate vaccination on pneumonia in The Gambia: population-based surveillance and case-control studiesGrant A Mackenzie, Philip C Hill, Shah M Sahito, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Social Science & Medicine (1982)|November 5, 2025
Adults with sickle-cells in a migration-driven rare disease setting: Therapeutic remoteness and graphic medicine in AustriaEva-Maria Knoll
Social Science & Medicine (1982)|February 13, 2026
Rare diseases, global health, and local contextsMałgorzata Rajtar, Eva-Maria Knoll
Gates Open Research|August 11, 2023
Worldwide Index of Serotype-Specific Pneumococcal Antibody Responses (WISSPAR): A curated database of clinical trial dataStephanie Perniciaro, Dominic Cooper-Wooton, Maria Knoll, et al.
Health Affairs (Project Hope)|October 14, 2016
Modeling The Economic Burden Of Adult Vaccine-Preventable Diseases In The United StatesSachiko Ozawa, Allison Portnoy, Hiwote Getaneh, et al.
Lancet (London, England)|June 13, 2006
Pneumococcal vaccination in developing countriesOrin S Levine, Katherine L O'Brien, Maria Knoll, et al.
The Lancet. Infectious Diseases|February 22, 2016
Effect of the introduction of pneumococcal conjugate vaccination on invasive pneumococcal disease in The Gambia: a population-based surveillance studyGrant A Mackenzie, Philip C Hill, David J Jeffries, et al.
The Lancet. Infectious Diseases|July 19, 2021
Impact of the introduction of pneumococcal conjugate vaccination on invasive pneumococcal disease and pneumonia in The Gambia: 10 years of population-based surveillance, Grant A Mackenzie, Philip C Hill, et al.
The Lancet. Infectious Diseases|June 12, 2017
Impact of the introduction of pneumococcal conjugate vaccination on pneumonia in The Gambia: population-based surveillance and case-control studiesGrant A Mackenzie, Philip C Hill, Shah M Sahito, et al.
Pageof 1